Home Top News and Stories UAE and Dubai News Headlines MOHAP begins Sinopharm trials on children aged three to 17

MOHAP begins Sinopharm trials on children aged three to 17

0
   

MOHAP begins Sinopharm trials on children aged three to 17

“Safety is the most important concern of the study”… The UAE’s Ministry of Health and Prevention (MOHAP) announced today that it has initiated a Sinopharm vaccine study on children aged three to 17. Trials on younger volunteers are already going on in China, the United States, United Kingdom and India, but this immune bridge study […]

The post MOHAP begins Sinopharm trials on children aged three to 17 appeared first on What’s On.